Prevalence and architecture of de novo mutations in developmental disorders.
Deciphering Developmental Disorders Study
Nature Publishing Group
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
The genomes of individuals with severe, undiagnosed developmental disorders are enriched in damaging de novo mutations (DNMs) in developmentally important genes. Here we have sequenced the exomes of 4,293 families containing individuals with developmental disorders, and meta-analysed these data with data from another 3,287 individuals with similar disorders. We show that the most important factors influencing the diagnostic yield of DNMs are the sex of the affected individual, the relatedness of their parents, whether close relatives are affected and the parental ages. We identified 94 genes enriched in damaging DNMs, including 14 that previously lacked compelling evidence of involvement in developmental disorders. We have also characterized the phenotypic diversity among these disorders. We estimate that 42% of our cohort carry pathogenic DNMs in coding sequences; approximately half of these DNMs disrupt gene function and the remainder result in altered protein function. We estimate that developmental disorders caused by DNMs have an average prevalence of 1 in 213 to 1 in 448 births, depending on parental age. Given current global demographics, this equates to almost 400,000 children born per year.
The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the UK Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the UK Department of Health. The research team acknowledges the support of the National Institutes for Health Research, through the Comprehensive Clinical Research Network. D.R.F. is funded through an MRC Human Genetics Unit program grant to the University of Edinburgh.
This is the author accepted manuscript. The final version is available from Nature via the DOI in this record.
Vol. 542, pp. 433 - 438
Place of publication
Showing items related by title, author, creator and subject.
Australin: a chromosomal passenger protein required specifically for Drosophila melanogaster male meiosis. Gao, S; Giansanti, MG; Buttrick, GJ; Ramasubramanyan, S; Auton, A; Gatti, M; Wakefield, JG (Rockefeller University Press, 2008-02-11)The chromosomal passenger complex (CPC), which is composed of conserved proteins aurora B, inner centromere protein (INCENP), survivin, and Borealin/DASRA, localizes to chromatin, kinetochores, microtubules, and the cell ...
Studholme, DJ; Rawlings, ND; Barrett, Alan J.; Bateman, A (BioMed Central, 2003-05-09)BACKGROUND: We wished to compare two databases based on sequence similarity: one that aims to be comprehensive in its coverage of known sequences, and one that specialises in a relatively small subset of known sequences. ...
Pocha, SM; Cory, GO (Wiley-Blackwell, 2009-01)The (Wiskott-Aldrich Syndrome Protein)-family verprolin homologous protein (WAVE) family of proteins occupies a pivotal position in the cell, converting extracellular signals into the formation of branched filamentous (F) ...